Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.37B |
| 4 |
Linde
LIN
|
+$756M |
| 5 |
DuPont de Nemours
DD
|
+$595M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.51B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$315M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$314M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
PPLI
People Inc
PPLI
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.07% |
| 2 | Financials | 6.12% |
| 3 | Healthcare | 5.17% |
| 4 | Consumer Discretionary | 4.88% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
National Bank Holdings
NBHC
$1.94B
| $1.14M | ﹤0.01% |
43,285
+6,918
| +19% | +$190K |
|
2552
Minerals Technologies
MTX
$2.26B
| $1.13M | ﹤0.01% |
22,200
-1,453
| -6% | -$71.9K |
|
|
SCS
2553
DELISTED
Steelcase
SCS
| $1.13M | ﹤0.01% |
111,961
-2,922
| -3% | -$31.4K |
|
2554
Trustmark
TRMK
$2.82B
| $1.13M | ﹤0.01% |
52,781
+4,856
| +10% | +$112K |
|
2555
Extreme Networks
EXTR
$3.24B
| $1.13M | ﹤0.01% |
280,372
+87,167
| +45% | +$379K |
|
2556
Sensient Technologies
SXT
$5.53B
| $1.13M | ﹤0.01% |
19,544
-5,637
| -22% | -$311K |
|
2557
PUT
Cardinal Health
CAH
$54.1B
| $1.13M | ﹤0.01% |
24,000
-1,800
| -7% | -$92.4K |
|
|
XRN
2558
Chiron Real Estate Inc
XRN
$488M
| $1.13M | ﹤0.01% |
16,702
-669
| -4% | -$41.9K |
|
2559
Murphy Oil
MUR
$5.04B
| $1.13M | ﹤0.01% |
126,281
+3,675
| +3% | +$47.2K |
|
2560
Assembly Biosciences
ASMB
$624M
| $1.13M | ﹤0.01% |
5,697
-7,413
| -57% | -$1.87M |
|
2561
CALL
Las Vegas Sands
LVS
$29.9B
| $1.13M | ﹤0.01% |
24,100
-121,700
| -83% | -$5.82M |
|
2562
CALL
VF Corp
VFC
$5.8B
| $1.12M | ﹤0.01% |
16,000
| – | – |
|
2563
PUT
Sarepta Therapeutics
SRPT
$1.88B
| $1.12M | ﹤0.01% |
8,000
-24,000
| -75% | -$3.65M |
|
2564
CALL
BHP
BHP
$222B
| $1.12M | ﹤0.01% |
24,326
-23,765
| -49% | -$1.14M |
|
2565
Acuity Brands
AYI
$10.6B
| $1.12M | ﹤0.01% |
10,939
-7,641
| -41% | -$785K |
|
2566
Camping World
CWH
$664M
| $1.12M | ﹤0.01% |
37,596
-5,860
| -13% | -$191K |
|
|
DX
2567
Dynex Capital
DX
$3.25B
| $1.12M | ﹤0.01% |
73,444
-27,920
| -28% | -$427K |
|
2568
Grand Canyon Education
LOPE
$3.75B
| $1.12M | ﹤0.01% |
13,988
-34,920
| -71% | -$3.16M |
|
2569
CRISPR Therapeutics
CRSP
$5.15B
| $1.12M | ﹤0.01% |
13,357
+13,246
| +11,933% | +$1.17M |
|
|
GOGL
2570
DELISTED
Golden Ocean Group
GOGL
| $1.12M | ﹤0.01% |
292,347
+68,988
| +31% | +$264K |
|
2571
Greif
GEF
$5.04B
| $1.11M | ﹤0.01% |
30,709
-7,476
| -20% | -$276K |
|
2572
MarineMax
HZO
$1.15B
| $1.11M | ﹤0.01% |
43,283
+7,822
| +22% | +$215K |
|
|
AQUA
2573
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $1.11M | ﹤0.01% |
52,301
-13,800
| -21% | -$275K |
|
2574
CALL
PNC Financial Services
PNC
$102B
| $1.11M | ﹤0.01% |
10,100
| – | – |
|
2575
City Holding Co
CHCO
$2.08B
| $1.11M | ﹤0.01% |
19,255
+4,509
| +31% | +$282K |
|
Similar funds
Barclays's Q3 2020 Portfolio in Review
As of Q3 2020, Barclays held 5,906 positions worth $168B, up 30% from $129B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays deployed $26.3B of net new capital in Q3 2020, opening 241 new positions and adding to 1,886 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 9.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $1.51B trimmed.
- Barclays's largest Q3 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
- Barclays added most to Visa in Q3 2020, an estimated $2.17B increase.
- Barclays's biggest Q3 2020 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $1.51B.
- Barclays fully exited People Inc in Q3 2020, selling an estimated $239M.
- Barclays's ten largest holdings make up 34% of its $168B portfolio in Q3 2020.
- Barclays opened 241 new positions and closed 676 in Q3 2020.
- Barclays's portfolio value rose 30% quarter-over-quarter to $168B.
Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.